Long-term benefits of monteplase before coronary angioplasty in acute myocardial infarction

被引：10

作者：

Inoue, T

Nishiki, R

Kageyama, M

Chida, R

Hayashi, T

Takayanagi, K

Hikichi, Y

Node, K

机构：

[1] Saga Univ, Fac Med, Dept Cardiovasc & Renal Med, Saga 8498501, Japan

[2] Eisai & Co Ltd, Dept Pharmaceut, Tokyo, Japan

[3] Eisai & Co Ltd, Prod Planning Div, Tokyo, Japan

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2005年 / 95卷 / 04期

关键词：

D O I：

10.1016/j.amjcard.2004.09.061

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

Patients with acute myocardial infarction were randomly assigned to receive direct: percutaneous coronary intervention (PCI) or pretreatment with intravenous monteplase followed by PCI. Although the combination of monteplase and PCI did not alter mortality compared with direct PCI there was a dramatic reduction in the cardiac event rate over a 2-year follow-up compared with direct PCI. (C) 2005 by Excerpts Medica Inc.

引用

页码：506 / 508

页数：3

共 8 条

[1]

CORRELATION OF BASELINE PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITY WITH PATENCY OF THE INFARCT ARTERY AFTER THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION [J].

BARBASH, GI ;

HOD, H ;

ROTH, A ;

MILLER, HI ;

RATH, S ;

ZAHAV, YH ;

MODAN, M ;

ZIVELIN, A ;

LANIADO, S ;

SELIGSOHN, U .

AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (19) :1231-1235

[2]

COLLEN D, 1994, THROMB HAEMOSTASIS, V72, P98

[3]

Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis [J].

Kamishirado, H ;

Inoue, T ;

Mizoguchi, K ;

Uchida, T ;

Nakata, T ;

Sakuma, M ;

Takayanagi, K ;

Morooka, S .

AMERICAN HEART JOURNAL, 2002, 144 (02) :303-308

[4]

A prospective, randomized, double-blind multicenter trial of a single bolus injection of the novel modified t-PA E6010 in the treatment of acute myocardial infarction: Comparison with native t-PA [J].

Kawai, C ;

Yui, Y ;

Hosoda, S ;

Nobuyoshi, M ;

Suzuki, S ;

Sato, H ;

Takatsu, F ;

Motomiya, T ;

Kanmatsuse, K ;

Kodama, K ;

Yabe, Y ;

Minamino, T ;

Kimata, SI ;

Nakashima, M ;

Sugiyama, M ;

Sone, T ;

Hiasa, Y ;

Kijima, M ;

Nakamura, N ;

Hayasaki, K ;

Abe, H ;

Kadowaki, K ;

Murayama, H ;

Joh, T ;

Katagiri, T ;

Watanabe, S ;

Dohi, K ;

Tateda, K ;

Murata, M ;

Hayashida, N ;

Arita, M ;

Sakai, K ;

Kita, T ;

Toda, H ;

Meguro, T ;

Harada, M ;

Higuma, N ;

Nagai, T ;

Takizawa, A ;

Hirayama, H ;

Murakami, E ;

Hirose, K ;

Ishise, S ;

Shimomura, K ;

Inada, M ;

Chino, M ;

Hiramori, K ;

Yokoyama, K ;

Munakata, T ;

Takase, S .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (07) :1447-1453

[5]

Low-dose tissue plasminogen activator followed by planned rescue angioplasty reduces time to reperfusion for acute myocardial infarction treated at community hospitals [J].

Kimura, K ;

Tsukahara, K ;

Usui, T ;

Okuda, J ;

Kitamura, Y ;

Kosuge, M ;

Sano, T ;

Tohyama, S ;

Yamanaka, O ;

Yoshii, Y ;

Umemura, S .

JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 2001, 65 (10) :901-906

[6]

OHNISHI A, 1994, JPN J CLIN PHARM THE, V25, P551

[7]

SANE DC, 1991, THROMB HAEMOSTASIS, V65, P275

[8]

THROMBOLYTIC PROPERTIES OF A NOVEL MODIFIED HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR (E6010) - A BOLUS INJECTION OF E6010 HAS EQUIVALENT POTENCY OF LYSING YOUNG AND AGED CANINE CORONARY THROMBI [J].

SUZUKI, S ;

SAITO, M ;

SUZUKI, N ;

KATO, H ;

NAGAOKA, N ;

YOSHITAKE, S ;

MIZUO, H ;

YUZURIHA, T ;

YUI, Y ;

KAWAI, C .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 (05) :738-746

← 1 →